Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

NCT00770458 is registered in ClinicalTrials.gov with Sequenom, Inc. as lead sponsor.

NCT NCT00770458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00770458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Lead sponsor
Sequenom, Inc.
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
December 31, 2009
Enrollment
1,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome (trisomy 21), edwards syndrome (trisomy 18), patau syndrome (trisomy 13), turner syndrome